Wei-Li Shao on Omada’s IPO & the Rapidly Evolving GLP-1 Market (#501)

Wei-Li Shao returns to talk about Omada Health’s IPO, the rapidly evolving landscape of GLP-1 therapies, market complexities associated with AI-driven innovation, and what it all tells us about consumer behaviors.

All that, plus the Flava of the Week comparing funding trends from Rock Health and Fitt Insider’s latest reports. Where are checks being written for digital health, and what parallels are we seeing in the greater wellness landscape?

ANNOUNCING THE RAP COLLABORATIVE

Exciting news! We’re launching the Rap Collaborative, a curated group of founders, builders, and operators working together to grow the adoption of consumer-centered health. Through content, community, and co-creation, members help shape what’s next and get their perspective in front of the industry.

Interested in being part of it? Contact jared@ulteradigital.com.

(#501)

See omnystudio.com/listener for privacy information.